Personalized Search
Displaying 81 - 100 of 1079
ABSTRACT
Over the last decade, there have been significant advancements in the treatment for patients with
acute myeloid leukemia
acute myeloid leukemia:
(uh-KYOOT my-uh-LOYD loo-KEE-mee-uh) A cancer of the blood cells. It happens when very young white blood cells (blasts) in the bone marrow fail to mature. The blast cells stay in the bone marrow and become to numerous. This slows…
Article last updated
.
Node ID (debugging only): 1543
Significant progress in the characterization of molecular pathogenic events in
acute myeloid leukemia
acute myeloid leukemia:
(uh-KYOOT my-uh-LOYD loo-KEE-mee-uh) A cancer of the blood cells. It happens when very young white blood cells (blasts) in the bone marrow fail to mature. The blast cells stay in the bone marrow and become to numerous. This slows production of red blood cells and…
Article last updated
.
Node ID (debugging only): 1542
A roundtable discussion on
anemia
anemia:
(uh-NEE-mee-uh) A condition in which there is a shortage of red blood cells in the bloodstream. This causes a low red blood cell count. Symptoms of anemia are fatigue and tiredness.
management in
myelodysplastic syndromes
myelodysplastic syndromes:
(my-eh-lo-diss-PLASS-tik SIN-dromez) A group of disorders where the bone marrow does…
Article last updated
.
Node ID (debugging only): 1541
Key Points
The ICC and WHO5 differently classify 64% of TP53-mutated disease due to distinct criteria for multihit TP53 mutations and TP53-mutated AML.
MDS with a single TP53
mutation
mutation:
Any change or alteration in a gene. A mutation may cause disease or may be a normal variation. Paroxysmal nocturnal hemoglobinuria (PNH) occurs because of a mutation in the PIG-A gene of a…
Article last updated
.
Node ID (debugging only): 1540
Interim results of the ACROBAT study suggest that increasing microchimerism and loss of complete chimerism may indicate relapse risk in patients with
acute myeloid leukemia
acute myeloid leukemia:
(uh-KYOOT my-uh-LOYD loo-KEE-mee-uh) A cancer of the blood cells. It happens when very young white blood cells (blasts) in the bone marrow fail to mature. The blast cells stay in the bone…
Article last updated
.
Node ID (debugging only): 1539
Abstract
Myeloid neoplasms originate from the clonal proliferation of hematopoietic
stem cells
stem cells:
Cells in the body that develop into other cells. There are two main sources of stem cells. Embryonic stem cells come from human embryos and are used in medical research. Adult stem cells in the body repair and maintain the organ or tissue in which they are found. Blood-forming (…
Article last updated
.
Node ID (debugging only): 1538
Presenter: Mikkael SekeresProfessor of Medicine, Chief, Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of MedicineMiami, FL, USA
Release Date: December 20, 2024
Congress: ASH 2024
Area: Hematology
Description:
Mikkael A. Sekeres…
Article last updated
.
Node ID (debugging only): 1535
Several years ago, I wrote an emotionally difficult article titled "Will I Reach My Goal?" It was about a book I was writing. The book describes my life and what it was like being hard of hearing in the 60s and 70s without any support in the schools. It covers my experiences within the deaf community and how difficult it was when I lost more hearing from
chemotherapy
chemotherapy:
(kee-…
Article last updated
.
Node ID (debugging only): 1534
Key Points
VEN plus HMA induces superior response rates in patients with R/R AML than conventional salvage therapy.
The VEN plus HMA combination allows for a safe and effective bridging to allo-HCT.
Abstract
The B-cell lymphoma 2 inhibitor
venetoclax
venetoclax:
Venetoclax is used to treat chronic lymphocytic leukemia or small lymphocytic leukemia in adults. Venetoclax is used alone or…
Article last updated
.
Node ID (debugging only): 1533
Recent advances in
acute myeloid leukemia
acute myeloid leukemia:
(uh-KYOOT my-uh-LOYD loo-KEE-mee-uh) A cancer of the blood cells. It happens when very young white blood cells (blasts) in the bone marrow fail to mature. The blast cells stay in the bone marrow and become to numerous. This slows production of red blood cells and platelets. Some cases of MDS become…
(AML) come from…
Article last updated
.
Node ID (debugging only): 1532
Ziftomenib plus standard cytarabine and
daunorubicin
daunorubicin:
Daunorubicin is in a class of medications called anthracyclines. It works by slowing or stopping the growth of cancer cells in your body. It is used in combination with other chemotherapy drugs to treat a certain type of acute myeloid leukemia (AML).
chemotherapy
chemotherapy:
(kee-moe-THER-uh-…
Article last updated
.
Node ID (debugging only): 1531
Two new studies led by researchers at Washington University School of Medicine in St. Louis have identified a possible way to block the progression of several forms of blood cancer using a drug already in
clinical trials
clinical trials:
Clinical research is at the heart of all medical advances, identifying new ways to prevent, detect or treat disease. If you have a bone marrow failure…
Article last updated
.
Node ID (debugging only): 1530
In this issue of Blood, Antypiuk et al, utilizing a murine model, demonstrate that
iron overload
iron overload:
A condition that occurs when too much iron accumulates in the body. Bone marrow failure disease patients who need regular red blood cell transfusions are at risk for iron overload. Organ damage can occur if iron overload is not treated.
(IOL), accumulated via a
mutation…
Article last updated
.
Node ID (debugging only): 1529
Myelodysplastic syndromes
Myelodysplastic syndromes:
(my-eh-lo-diss-PLASS-tik SIN-dromez) A group of disorders where the bone marrow does not work well, and the bone marrow cells fail to make enough healthy blood cells. Myelo refers to the bone marrow. Dysplastic means abnormal growth or development. People with MDS have low blood cell count for at…
/neoplasms (MDS) are a widely…
Article last updated
.
Node ID (debugging only): 1528
Axatilimab-csfr (Niktimvo), a CSF-1R–targeting agent that reduces the drivers of inflammation and
fibrosis
fibrosis:
(fie-BRO-suss) Scarring of tissue. Fibrosis of the bone marrow is an feature seen in some types of unclassified myeldysplastic syndrome (MDS).
, has been approved by the FDA in 9 mg and 22 mg vial sizes to treat adult and pediatric patients with
graft-versus-host…
Article last updated
.
Node ID (debugging only): 1527
Panelists discuss how long-term analysis of the ELEMENTS trial reveals significant improvements in
red blood cell
red blood cell:
The most numerous type of blood cell in healthy people. Red blood cells contain hemoglobin, a protein that picks up oxygen in the lungs and brings it to cells in all parts of the body. Also called erythrocyte, RBC.
(RBC) transfusion burden and
hemoglobin…
Article last updated
.
Node ID (debugging only): 1526
Watch these sessions 2024 Patient and Family Conference, held in partnership with the University of Chicago.
Aplastic Anemia
Advances in Treating PNH
Fatigue Management
Conference Event last updated
.
Node ID (debugging only): 870
In this issue of Blood, Pidala et al report on the results of a multicenter phase 2 trial, in which a
graft-versus-host disease (GVHD)
graft-versus-host disease (GVHD):
Also called GVHD, it is a common complication of bone marrow/stem cell transplantation. It is caused when the donor's immune cells, now in the patient, begin to see the the patient's body as…
Article last updated
.
Node ID (debugging only): 1525
TITLE
Azacitidine
Azacitidine:
It works by reducing the amount of methylation in the body. Methylation is a process that acts like a switch to turn off or “silence” genes in certain cells. When these genes (called tumor suppressor genes) are turned off, MDS cells and cancer cells can grow freely. Azacitidine is approved by the U…
and
venetoclax
venetoclax:
Venetoclax is…
Article last updated
.
Node ID (debugging only): 1524
Allogeneic hematopoietic cell transplantation (HCT) is a potentially curative treatment for severe
aplastic anemia
aplastic anemia:
(ay-PLASS-tik uh-NEE_mee-uh) A rare and serious condition in which the bone marrow fails to make enough blood cells - red blood cells, white blood cells, and platelets. The term aplastic is a Greek word meaning not to form. Anemia is a condition that…
Article last updated
.
Node ID (debugging only): 1523